基层医疗中慢阻肺系统性病例发现的长期成本效果模型评估
本研究基于Markov决策分析模型,比较英国基层医疗中对≥50岁吸烟者每3年一次系统性慢阻肺病例发现与常规诊疗的长期成本效果。
要点
- 初筛问卷应答率和确诊肺功能检查出席率是主要驱动因素
核心结论
- 在基层医疗中使用筛查问卷定期进行慢阻肺系统性病例发现,尽管治疗有效性存在不确定性,长期来看很可能具有成本效果。
研究设计与样本
- 开发Markov决策分析模型,比较每3年一次系统性病例发现方案与英国基层医疗当前常规诊断流程的成本效果。
- 目标人群为年龄≥50岁的曾经吸烟者,病例发现路径的患者层面数据来自一项大型随机对照试验。
- 慢阻肺自然史和治疗效果信息来自关联的慢阻肺队列、英国基层医疗数据库和已发表文献。
- 从卫生服务视角计算每获得一个质量调整生命年(QALY)的贴现终身成本。
主要发现
- 基础案例分析对多项单因素敏感性分析稳健。
- 主要驱动因素为初始筛查问卷的应答率和确诊肺功能检查的出席率。
临床怎么用
- 在基层医疗中对≥50岁曾经吸烟者考虑每3年一次使用筛查问卷进行慢阻肺系统性病例发现。
- 实施时需关注提高初筛问卷应答率和确诊肺功能检查出席率以保障成本效果。
局限性
- 治疗有效性存在不确定性。
- 对病例发现患者的自然史和管理有效性认识不足,需进一步研究以提高实施信心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: 'One-off' systematic case-finding for COPD using a respiratory screening questionnaire is more effective and cost-effective than routine care at identifying new cases. However, it is not known whether early diagnosis and treatment is beneficial in the longer term. We estimated the long-term cost-effectiveness of a regular case-finding programme in primary care. METHODS: A Markov decision analytic model was developed to compare the cost-effectiveness of a 3-yearly systematic case-finding programme targeted to ever smokers aged ≥50 years with the current routine diagnostic process in UK primary care. Patient-level data on case-finding pathways was obtained from a large randomised controlled trial. Information on the natural history of COPD and treatment effects was obtained from a linked COPD cohort, UK primary care database and published literature. The discounted lifetime cost per quality-adjusted life-year (QALY) gained was calculated from a health service perspective. RESULTS: The incremental cost-effectiveness ratio of systematic case-finding versus current care was £16 596 per additional QALY gained, with a 78% probability of cost-effectiveness at a £20 000 per QALY willingness-to-pay threshold. The base case result was robust to multiple one-way sensitivity analyses. The main drivers were response rate to the initial screening questionnaire and attendance rate for the confirmatory spirometry test. DISCUSSION: Regular systematic case-finding for COPD using a screening questionnaire in primary care is likely to be cost-effective in the long-term despite uncertainties in treatment effectiveness. Further knowledge of the natural history of case-found patients and the effectiveness of their management will improve confidence to implement such an approach.
引用
- Lambe T, Adab P, Jordan RE, et al. Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care. Thorax. 2019. PMID: 31285359. doi:10.1136/thoraxjnl-2018-212148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。